The 2022 event will be more significant than ever before due to the transition period after Brexit coming to an end. As such, the UK will no longer be part of the EU free market. This will mean increased medicines prices, reduced access to some specialist drugs and greater risk of supply chain shortages. In a post-Brexit environment, exhaustion of rights will cease to apply to the UK, making import and export a costly business and in a worst-case scenario could effectively kill parallel distribution.
This conference will bring together industry experts to discuss the challenges and drivers of the industry, including the EU regulatory landscape and the impact of the Brexit and the Pandemic together. The conference will also provide global insights on Parallel trade and will reflect on key takeaways for other member states.
Book on or before 28th January to receive £100 off the conference price
Register online today at: www.parallel-trade.com or call Yasmin Alsadoon, Director on +44 (0)20 7827 6164 or email yalsadoon ( @ ) smi-online dot co dot uk
Co-Chairs For 2022:
Christopher Stothers, Partner,Freshfields Bruckhaus Deringer LLP
Eric Noehrenberg, Vice President and Global Head of Market Access and Goverment Affairs, Corcym
Key Speakers Include:
Martin Howe, Queens Counsel, 8 New Square
Shabnam Hanassab, Engagement Manager, iQvia
Tushar Patel, Technical Director, Key Pharmaceuticals Ltd
Dermot Glynn, Senior Advisor, Europe Economics
Stefan Enchelmaier, Professor of European and Comparative Law, Tutor in Jurisprudence, lincoln College, GB-Oxford
Hynek Valerián, Group Parallel Trade Manager, Dr.Max group
Jackie Mulryne, Partner, Arnold & Porter
Peter Bogaert, Managing Partner, Covington & Burling
…and many more
Key Benefits of attending:
Discover the impact of Covid-19 on Parallel trade as countries begin to release restrictions. How has the sector been influenced?
Engage in discussions on the growth within parallel trade over the past year at the only Parallel Trade specific conference within the EU.
Discuss the impact on UK parallel trade following Brexit, through the eyes of regulators, the pharmaceutical industry and academics
Develop further understanding of the rules and regulation changes over the past 12 months, Parallel Trade, where are we now?
Who should attend:
Vice President/ Heads of/General Managers:
International Trade and Relations
Supply Chain Development Brexit
Supply Chain Manager
Parallel trade reporting
Policy Patent Operations
Supply and Demand
SMi Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages. For details contact
Plus, Two post-conference interactive workshops
Workshop A : Parallel Trade lets talk details
Workshop Leader: Tushar Patel, Technical Director, Key Pharmaceuticals Ltd
Workshop Overview: This workshop will discuss all of the main topics within parallel trade, looking back to understand the future. There will be highlights on the history of parallel imports and how this works with the UK. The workshop will also highlight parallel trade and Brexit, discussing where we are now and what strategies are currently being used, do they give parallel traders and advantage and how will Brexit effect parallel trade in the long term. The workshop will highlight the challenges and successes of the industry and will also allow for open discussion on the future of this industry.
This workshop will allow you to:
Discover the future of parallel trade, based on the history we have
Understand where we are now, how has Brexit effected the parallel
Interact with industry professionals with Q&A sessions.
Speak with Tushar Patel about current trading models and the specifi c
challenges for different industry professionals.
Workshop B: The Case Law of Parallel Imports
Workshop Leader: Stefan Enchelmaier, Professor of European and Comparative Law, Tutor in Jurisprudence, Lincoln College, GB-Oxford
Workshop Overview: This workshop will allow attendees to discuss and build their understanding of case law within Parallel Trade. With interactive sessions, opportunities to question and learn, this workshop will discuss national IP rights and the trade of COVID 19 vaccines. There will be highlights of Professor Stefan Enchelmaiers work and case studies, focusing on re-packaging and intellectual property.
This workshop will allow you to:
Discover when parallel trade is permissible
Engage in interactive sessions about case law with a focus on packaging
Discuss potential cases with Stefan and understand develop your understanding of the movement of free goods.
Additional Contact Info:
T: +44 (0)20 7827 6088
E: rjones ( @ ) smi-online dot co dot uk
LinkedIn: ( @ ) SMi Pharma
Twitter: ( @ ) SMiPharm #SMi #SMiParallel
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk